Streetbeat News

Analyst Ratings

WOR

Worthington Industries (NYSE:WOR) reported Q4 earnings of $2.74 per share, beating the analyst consensus estimate of $1.90 by 44.21%. This is a 73.42% increase from the same period last year. However, the company's quarterly sales of $1.23 billion missed the analyst consensus estimate of $1.24 billion by 0.89%, marking a 19.14% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 8:18 pm

FC

Franklin Covey (NYSE:FC) reported Q3 earnings of $0.32 per share, beating the analyst consensus estimate of $0.22 by 45.45%. However, this is a 37.25% decrease from the same period last year. The company also reported quarterly sales of $71.40 million, beating the analyst consensus estimate of $69.62 million by 2.56%, and marking a 7.89% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2023 | 8:06 pm

GPC

In the last quarter, analysts have provided 3 bullish and 2 indifferent ratings for Genuine Parts (NYSE:GPC). The company has an average 12-month price target of $181.6, a decrease of 2.1% from the previous average price target of $185.50.

Portfolio Pulse from Benzinga Insights

June 28, 2023 | 8:01 pm

XPO

Over the last quarter, XPO Logistics (NYSE:XPO) has received a mix of bullish and indifferent analyst ratings, with no bearish views. In the last 3 months, 20 analysts have offered 12-month price targets for XPO, with an average price target of $51.0, up 6.74% from the previous average of $47.78.

Portfolio Pulse from Benzinga Insights

June 28, 2023 | 8:01 pm

LECO

Analysts have provided somewhat bullish ratings for Lincoln Electric Holdings (NASDAQ:LECO) in the last quarter, with 6 out of 7 analysts being somewhat bullish and 1 being indifferent. The company has an average price target of $187.86, which has increased by 12.22% from the previous average price target of $167.40.

Portfolio Pulse from Benzinga Insights

June 28, 2023 | 8:00 pm

TMHC

In the last quarter, Taylor Morrison Home (NYSE:TMHC) has received 2 somewhat bullish and 4 indifferent analyst ratings. The average 12-month price target for the company has increased by 21.32% from the previous average, now standing at $49.5.

Portfolio Pulse from Benzinga Insights

June 28, 2023 | 8:00 pm

NVRO

17 analysts have provided ratings for Nevro (NYSE:NVRO) in the last quarter, with an average price target of $39.24, implying an upside from the current price of $25.84. The current average represents a 7.56% decrease from the previous average price target of $42.45.

Portfolio Pulse from Benzinga Insights

June 28, 2023 | 8:00 pm

MNMD

Analysts have provided bullish ratings for Mind Medicine (NASDAQ:MNMD) within the last quarter, with 7 total bullish ratings and 3 somewhat bullish ratings. The average 12-month price target for Mind Medicine is $34.3, a decrease of 54.27% from the previous average price target of $75.00.

Portfolio Pulse from Benzinga Insights

June 28, 2023 | 8:00 pm

REGN

Regeneron Pharmaceuticals' stock continues to fall after the FDA issued a Complete Response Letter (CRL) for aflibercept 8 mg Biologics License application due to an ongoing review of inspection findings at a third-party filler. This effectively denied the company approval of a higher-dose version of EYLEA. Several analysts also lowered their price targets on the stock.

Portfolio Pulse from Ryan Gustafson

June 28, 2023 | 7:53 pm

AMGN

Amgen's (NASDAQ:AMGN) short percent of float has fallen 4.93% since its last report, indicating a more bullish sentiment towards the stock. The company has 7.20 million shares sold short, which is 1.35% of all regular shares available for trading. Compared to its peers, Amgen has less short interest as a percentage of float, with an average of 4.18%.

Portfolio Pulse from Benzinga Insights

June 28, 2023 | 7:45 pm